Good report. Highlights for me:
Project Valuation: Our after-tax valuation (based on a 10% discount rate, 100% equity basis and 30-year mine life) A$424M or A$0.78 per share. The base case assumes a long-term NdPr price of US$67/kg, which is similar to the current spot price. We consider this to be a conservative price forecast based on the demand outlook. Each US$10/kg increase in the NdPr price increases the assessed after-tax NPV by ~A$240M or ~A$0.44 per share.
ASX-Listed Peer Group Comparison: We have compared forecast operational and cost metrics for ARU and four other ASX-listed magnet metal development companies, as well as benchmarking against the current producer LYC. ARU is a stand-out in this emerging producer group in relation to having the lowest projected operating costs (US$ per kg NdPr oxide), long mine life, low sovereign-risk mining jurisdiction and low ratio of enterprise value to projected NdPr production.
Gold Company Analogy: We have taken our steady state production and earnings forecasts for ARU and re-stated them in terms of the equivalent that a gold mining company would need to achieve. This analysis shows that ARU’s forecast FY2023 revenue and profitability is equivalent to that of a gold company producing ~240kozpa with an all-in sustaining cost of just US$632/ounce.
- Forums
- ASX - By Stock
- ARU
- Ann: Resource Capital Research Report
Ann: Resource Capital Research Report, page-2
Featured News
Add ARU (ASX) to my watchlist
(20min delay)
|
|||||
Last
17.5¢ |
Change
-0.005(2.78%) |
Mkt cap ! $443.5M |
Open | High | Low | Value | Volume |
17.5¢ | 17.5¢ | 17.5¢ | $189.7K | 1.084M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
30 | 1053441 | 17.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.5¢ | 349328 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
30 | 1053441 | 0.170 |
34 | 1637731 | 0.165 |
44 | 1543011 | 0.160 |
32 | 2342425 | 0.155 |
61 | 1632811 | 0.150 |
Price($) | Vol. | No. |
---|---|---|
0.175 | 349328 | 10 |
0.180 | 1353177 | 27 |
0.185 | 1440628 | 35 |
0.190 | 1454394 | 26 |
0.195 | 963545 | 22 |
Last trade - 10.21am 11/10/2024 (20 minute delay) ? |
Featured News
ARU (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online